Comments on New Approaches to Post Grant Reviews
The Pharmaceutical Research and Manufacturers of America (PhRMA) appreciates the opportunity to submit comments in connection with the Patent and Trademark Office’s (PTO or Office) Request for Comments on a Proposed Pilot Program Exploring an Alternative Approach to Institution Decisions in Post Grant Administrative Reviews.
PhRMA’s member companies are leading research-based pharmaceutical innovators devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA’s membership ranges in size from small emerging companies to multi-national corporations that employ tens of thousands of Americans, and encompasses both research-based pharmaceutical and biotechnology companies. The U.S. biopharmaceutical sector supports a total of 3.4 million jobs throughout the economy, and directly employs more than 810,000 Americans. The industry’s overall economic impact is substantial, accounting for nearly $800 billion in economic output.